Gotham Asset Management’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.6M Buy
134,651
+13,949
+12% +$2.76M 0.05% 534
2026
Q2
$22.6M Sell
120,702
-5,199
-4% -$759K 0.05% 520
2026
Q1
$12.2M Buy
125,901
+12,072
+11% +$1.22M 0.04% 631
2025
Q4
$9.07M Buy
113,829
+14,715
+15% +$965K 0.03% 665
2025
Q3
$4.63M Buy
+99,114
New +$3.88M 0.02% 802

Other funds holding RVMD

Gotham Asset Management's RVMD Position: Q3 2026 in Review

Gotham Asset Management increased its Revolution Medicines (RVMD) stake by 12% in Q3 2026, buying an estimated $2.76M and bringing the position to 134,651 shares worth $27.6M. The position accounts for 0.05% of the portfolio, ranked #534.

Gotham Asset Management first reported a position in RVMD in Q3 2025 and has held it in 5 quarters since. 760 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Gotham Asset Management held 134,651 shares of Revolution Medicines worth $27.6M as of Q3 2026.
  • Gotham Asset Management bought 13,949 Revolution Medicines shares in Q3 2026, an estimated $2.76M.
  • Revolution Medicines made up 0.05% of Gotham Asset Management's portfolio in Q3 2026, its #534 holding.
  • Gotham Asset Management first reported a position in Revolution Medicines in Q3 2025 and has held it in 5 quarters since.
  • 760 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.